Effect of Laughter Therapy on Breast Cancer Patients
Launched by PROF. DR. CEMIL TASCIOGLU EDUCATION AND RESEARCH HOSPITAL ORGANIZATION · Jun 12, 2025
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how laughter therapy can help breast cancer patients feel better before their surgery. The researchers want to see if laughing and having fun can reduce feelings of distress and depression, and improve overall psychological well-being. The trial will involve breast cancer patients who are scheduled for surgery at a city hospital. To participate, individuals must be at least 18 years old, agree to take part, and not have any serious health issues or previous experience with laughter yoga.
Participants in the trial will be randomly assigned to two groups. One group will receive laughter therapy sessions three times a week for about 30-45 minutes, while the other group will only receive standard nursing care. After the laughter therapy is completed, the researchers will check in with both groups at different times to see how they are doing. This study is not yet recruiting participants, but it aims to understand the potential benefits of laughter for those facing surgery for breast cancer.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Voluntary acceptance to participate in the study,
- • Being diagnosed with breast cancer and being in the patient group in which surgical operation is planned,
- • Not having participated in laughter yoga practice before,
- • Being literate,
- • Not having a psychiatric disease (diagnosis)
- • Not having a communication and understanding disability related to vision, hearing
- • Being in the age group of 18 and over
- Exclusion Criteria:
- • Not wanting to participate in the study,
- • Being in the patient group with a condition recommended not to do laughter yoga (having undergone surgery in the abdominal region in the last three months, uncontrolled hypertension, glaucoma, hernia, epilepsy),
- • Not having participated in any of the laughter yoga sessions,
- • Having physical restriction/respiratory problems and not being able to perform yoga movements.
About Prof. Dr. Cemil Tascıoglu Education And Research Hospital Organization
Prof. Dr. Cemil Taşcıoğlu Education and Research Hospital Organization is a leading clinical research institution dedicated to advancing medical knowledge and improving patient care through innovative research initiatives. With a strong focus on education and collaboration, the organization fosters an environment conducive to clinical trials that address pressing health challenges. It is committed to ethical standards and rigorous scientific methodologies, ensuring the safety and well-being of participants while contributing to the development of new therapies and treatments. The hospital's multidisciplinary team of experts works closely with healthcare professionals and researchers to translate findings into practical applications that enhance the quality of healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Servet Cihan
Principal Investigator
Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesi
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported